Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

FLR vs ACA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACA Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

ACA Overall Winner 6-Pillar Tally: FLR 3 – 3 ACA Matrix Metrics: FLR 3 – 7 ACA

As of Nov 16, 2026, Arcosa, Inc. (ACA) is the stronger overall head-to-head candidate over Fluor Corporation (FLR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). FLR carries a Unified Composite Score of 43.3/100 (HOLD) at $48.20 (14.9x Forward P/E, 2.1% operating margin), whereas ACA carries 60.0/100 (BUY) at $149.15 (29.1x Forward P/E, 12.3% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FLR vs ACA
FLR NYSE
Fluor Corporation
Heavy Construction Other Than Bldg Const - Contractors
$48.20
-1.6% 1D
Market Cap $6.3B
TTM Revenue $15.9B
Forward P/E 14.9x
Beta / 30D Vol 1.65β · 52% Vol
Unified Composite Score
43.3 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 58.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $47.15 · SMA50: $49.71
ACA NYSE Head-to-Head Winner
Arcosa, Inc. Common Stock
Fabricated Structural Metal Products
$149.15
+0.08% 1D
Market Cap $7.3B
TTM Revenue $1.19B
Forward P/E 29.1x
Beta / 30D Vol 0.92β · 4% Vol
Unified Composite Score
60.0 / 100 BUY
Tech 56.0 Fund 49.0 Flow 50.0 Mom 36.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 82
RSI-14: 82.2 · SMA20: $147.01 · SMA50: $146.08

6-Pillar Scorecard Institutional Category Breakdown (FLR 3 – 3 ACA)

Columns: Metric · FLR · ACA
1. Valuation Multiples FLR
Forward P/E 14.9x 29.1x
Trailing P/E 15.7x 36.4x
PEG Ratio 0.31x 1.86x
EV / Revenue 0.3x 6.1x
2. Growth & Scale FLR
Revenue Growth (YoY) +10.5% +1.7%
Earnings Growth (YoY) -94.5% +448.6%
TTM Revenue (USD) $15.9B $1.19B
Market Cap $6.3B $7.3B
3. Profitability & Quality ACA
Gross Margin 3.3% 22.8%
Operating Margin 2.1% 12.3%
Net Profit Margin -7.2% 16.8%
Return on Equity (ROE) -27.4% 8.0%
4. Balance Sheet & Cash Flow ACA
Cash Generation (TTM) -$425M $224M EBITDA
Cash Flow Margin -2.7% 18.8% EBITDA Mgn
Net Cash / Leverage $1.62B Net Cash $60.76 Book/Sh · 8.0% ROE
Dividend Yield None (0.00%) 0.14%
5. Options & Positioning FLR
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 45.0% (22nd %ile) 28.7% (6th %ile)
Put/Call OI Skew 0.34x (Call-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat ACA
OpEx & R&D Intensity 1.2% of Rev ($191M) 10.5% of Rev ($125M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Engineering & Construction Operator Engineering & Construction Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FLR (3) vs ACA (7)
Institutional Metric FLR ACA Criterion Row Edge
Market Capitalization
Scale
$6.3B $7.3B Larger Scale ACA
Trailing P/E Ratio
Valuation
15.7x 36.4x Lower Multiple FLR
Forward P/E Ratio
Valuation
14.9x 29.1x Lower Multiple FLR
Revenue Growth (YoY)
Growth
+10.5% +1.7% Higher Growth FLR
Operating Margin (TTM)
Profitability
2.1% 12.3% Higher Margin ACA
Net Profit Margin
Profitability
-7.2% 16.8% Higher Margin ACA
Return on Equity (ROE)
Capital Efficiency
-27.4% 8.0% Higher ROE ACA
52-Week Range Position
Momentum
47% ($39–$58) 100% ($91–$149) Stronger Trend ACA
Beta / 30D Volatility
Risk Regime
1.65β · 52% Vol 0.92β · 4% Vol Lower Realized Risk ACA
Unified Institutional Score
Composite Signal
43.3 / 100 (HOLD) 60.0 / 100 (BUY) Higher Composite ACA
Trailing 12M Revenue (USD)
Operating Scale
$15.9B $1.19B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
3.3% 22.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.31x PEG · 0.3x EV/Rev 1.86x PEG · 6.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$425M ($1.62B Net Cash) $224M EBITDA ($60.76 Book/Sh · 8.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACA +19.98 pp
FLR: -18.17% · ACA: +1.81%
3M Horizon ACA +19.66 pp
FLR: -16.8% · ACA: +2.86%
6M Horizon ACA +32.92 pp
FLR: -8.82% · ACA: +24.1%
1Y Horizon ACA +45.91 pp
FLR: +0.88% · ACA: +46.79%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FLR vs ACA. Trailing 12-month operating profitability (FLR 2.1% vs ACA 12.3%) and valuation multiples (FLR 14.9x vs ACA 29.1x Forward P/E) are benchmarked directly in Pillar 4 below.

FLR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$15.9B
Gross Margin3.3%
Op. Margin2.1%
ROE / Fwd P/E-27.4% · 14.9x
ACA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.19B
Gross Margin22.8%
Op. Margin12.3%
ROE / Fwd P/E8.0% · 29.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FLR CONSOLIDATION
70d in phase · OBV ACCUMULATION
Current IV 45.0%
IV Percentile 22nd %ile
Put/Call OI Skew 0.34x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact FLR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 28.7%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FLR Moat Profile Cyclical / Execution-Driven Positioning
Engineering & Construction Operator
Competes within the Engineering & Construction value chain with $6.3B market capitalization and 2.1% operating margin.
OpEx & R&D Reinvestment 1.2% of Rev ($191M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (10 partners):
Caterpillar Inc. Siemens AG GE Vernova Inc. Linde plc
ACA Moat Profile Cyclical / Execution-Driven Positioning
Engineering & Construction Operator
Competes within the Engineering & Construction value chain with $7.3B market capitalization and 12.3% operating margin.
OpEx & R&D Reinvestment 10.5% of Rev ($125M)
90D Engineering Disclosures 0 Published

Investor FAQ FLR vs ACA Key Questions & Quantitative Answers

As of Nov 16, 2026, Arcosa, Inc. (ACA) is the stronger overall head-to-head candidate over Fluor Corporation (FLR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). FLR carries a Unified Composite Score of 43.3/100 (HOLD) at $48.20 (14.9x Forward P/E, 2.1% operating margin), whereas ACA carries 60.0/100 (BUY) at $149.15 (29.1x Forward P/E, 12.3% operating margin). Technically, FLR sits in a Neutral phase (RSI 49.1, CONSOLIDATION options structure) and ACA sits in a Markup phase (RSI 82.2, UNCLASSIFIED options structure).

FLR leads the Growth & Scale pillar: FLR posts +10.5% YoY revenue growth and -94.5% YoY earnings growth on $15.9B TTM revenue (3.3% gross margin, 2.1% operating margin), compared with ACA at +1.7% YoY revenue growth and +448.6% YoY earnings growth on $1.19B TTM revenue (22.8% gross margin, 12.3% operating margin). On trailing 12-month operating scale, FLR generates $15.9B in USD-normalized revenue versus $1.19B for ACA. In operating R&D and SG&A reinvestment, FLR deploys 1.2% of Rev ($191M) (0 90-day corporate R&D disclosures) versus 10.5% of Rev ($125M) (0 disclosures) for ACA.

FLR screens cheaper on headline valuation multiples. FLR trades at 14.9x Forward P/E, 15.7x Trailing P/E, 0.31x PEG, and 0.3x EV/Revenue (-2.7% FCF margin), whereas ACA trades at 29.1x Forward P/E, 36.4x Trailing P/E, 1.86x PEG, and 6.1x EV/Revenue (18.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FLR (-27.4% ROE) versus ACA (8.0% ROE) capital efficiency.

In options market volatility and institutional positioning, FLR carries 45.0% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.34x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.65β · 52% Vol realized risk). By comparison, ACA carries 28.7% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.92β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.